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Background: HIV and hepatitis C (HCV) co-infection is highly common among Chinese injection drug users but it is
difficult to reach IDUs at traditional VCT (Voluntary HIV counseling treatment) clinics. A new national model integrating
HIV/HCV testing with methadone maintenance treatment was started in 2006. The purpose of this study was to
investigate HIV and HCV test uptake and associated factors at methadone clinics in Guangdong Province, China.
Methods: A cross-sectional design using routine surveillance data and laboratory testing confirmation was applied to
determine rates of HIV and HCV test uptake. Multi-level modeling was used to examine individual-level and clinic-level
correlates of increased test uptake.
Results: 45 out of 49 methadone clinics in Guangdong Province agreed to participate in the study. Among all 13,270
individuals, 10,046 (75.7%) had HIV test uptake and 10,404 (78.4%) had HCV uptake. At the individual level, methadone
clients 30 years or older were more likely to have HIV and HCV test uptake (p <0.001 for both). At the clinic level,
methadone clinics with greater health care personnel were more likely to have HIV (p =0.01) and HCV (p = 0.044) test
uptake. HIV test uptake significantly correlated with HCV test uptake (correlation coefficient=0.64).
Conclusion: Methadone clinics provide an opportunity for routine integrated HIV and HCV screening among drug
users in China. Increased test uptake in young drug users and increased health care personnel at clinics may further
improve screening.
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Early HIV testing and treatment are critical to the suc-
cess of comprehensive control programs, especially
among most-at-risk populations [1,2]. Although HIV
testing is offered in a variety of health care settings
across the world, poor test uptake among drug users
continues to be a common problem worldwide [3,4].
Currently less than half of HIV-infected individuals in
China know their serostatus among the estimated
780,000 HIV-infected individuals [5]. Modeling research
has suggested that increasing HIV testing fourfold in* Correspondence: lingli@mail.sysu.edu.cn
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reproduction in any medium, provided the orChina could avert over 42,000 HIV infection and 11,000
deaths [6]. Scaling up HIV testing has been challenging
in China. Traditional voluntary HIV counseling treat-
ment (VCT) testing has failed to reach many drug users
in China. Less than 20% of drug users in China received
HIV testing at VCT sites [7,8].
HIV and hepatitis C (HCV) co-infection is common
among Chinese injection drug users (IDUs) [9]. In one
study from southern China, 17.6% of IDUs had HCV in-
fection and in 95.1% of HCV-infected individuals also
had HIV infection [10]. Since HIV/HCV co-infection in-
creases mortality, cirrhosis, and hepatocellular carcin-
oma, scaling up integrated HIV and HCV testing is an
important public health priority [11].
To address these challenges, in 2006 China started a
model of HIV/HCV screening among drug users at
methadone maintenance treatment clinics (methadone. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and HCV infection were integrated into methadone
clinics and provided to all clients, although individuals
could still decline testing. Currently 700 methadone
clinics across China distribute methadone to 300,000
drug users and coverage continues to expand [14,15].
However, the extent to which this model successfully
implements HIV and HCV testing in China is currently
unknown. The purpose of this study was to examine
HIV and HCV test uptake at methadone clinics in
Guangdong Province, China and to identify individual
and clinic level factors associated with increased uptake.
Methods
Study site
Guangdong Province is located in southern China and
has the largest migrant population of any province [16].
The province has a system of 49 methadone clinics.
Methadone clients are self-referred or assigned treat-
ment as part of a post-incarceration rehabilitation plan
[13]. The system is administered by the National Centre
for AIDS/STD Control and Prevention within the Chinese
Centers for Disease Control and Prevention (Chinese
CDC). The system has associated clinics that distribute
methadone to recovering drug users. Guangdong’s 49
methadone clinics are distributed in 18 of the 23 cities of
the province.
Administrative management system
A national web-based national HIV/AIDS information
system was established by the Chinese CDC and in-
cludes methadone maintenance treatment as one of its
eight core subsystems [17].
The methadone clinic administrative database has
detailed records of all individuals, including socio-
demographic characteristics, drug use behaviors, and
HIV and HCV test uptake. Test uptake was defined as
laboratory confirmed completion of an HIV Western
Blot or HCV ELISA test. All surveys were completed
by local methadone clinic staff and entered into the na-
tional web-based administrative management system.
Survey items were developed by the National Working
Group for Community-based Maintenance Treatment
for Opiate Users [13].
Data source
We conducted a performance evaluation of the metha-
done maintenance program in Guangdong Province.
Data for all 49 methadone clinics opened before October
31, 2008 were collected during November and December
2008. Methadone clinic staff downloaded data and de-
leted all identifying information.
The director of each methadone clinic completed a de-
tailed questionnaire about their clinic including economicregion, administrative clinic level, affiliated institution,
clinic healthcare personnel (the total number of nurses
and physicians employed), number of patients, integration
of clinic with voluntary HIV counseling services, clinic fi-
nances (for profit or not), and average distance from client
residence to clinic (within five kilometers or further).
Data analysis
A total of 49 clinics were examined. Four clinics open
less than one month prior to the study were not in-
cluded in the analysis. 172 (1.3%) individuals were ex-
cluded from the analysis because they had three or
more individual-level variables missing in their data
set. Another 296 (2.2%) individuals were excluded be-
cause they initiated methadone maintenance treat-
ment in another province before transferring their care to
Guangdong.
The main study outcomes were HIV test uptake and
HCV test uptake. Group comparisons for categorical
data were examined with Chi-square tests at the individ-
ual level. HIV and HCV test uptake were examined
using nonparametric Kruskal-Wallis tests at the clinic
level. The correlation between HIV test uptake and
HCV test uptake was examined using a Pearson correl-
ation coefficient.
Given the hierarchical nature of the data, there was
potential clustering in outcomes and interactions be-
tween individual and clinic level factors of HIV and
HCV test outcomes. Multilevel analysis with random in-
tercepts was used to assess the effect of factors at the in-
dividual and clinical level on HIV and HCV test uptake.
To examine clustering at the clinic level, a random inter-
cept two-level null model with no explanatory variables
was first tested. Results were consistent with clustering at
the clinic level, supporting the use of a multilevel model.
The multilevel analysis used a two-level binomial logit
model that incorporated six individual level (level 1) var-
iables and eight clinic level variables (level 2). Individual
level socio-demographic characteristics included the fol-
lowing: sex, age (<30 years old, 30–39 years old, 40–
49 years old, >50 years old), marital status (married,
unmarried), education completed (none/primary school,
middle school, high school and above), and employment
status (employed, unemployed). Behavioral data in the
system included major drug type, injecting behaviors
(injecting, non-injecting), drug use method during
the past half year (injecting, smoking/snorting, mixing
injecting and smoking/snorting), needle sharing experience
(sharing, non-sharing) and detoxification experience (ever
had detoxification, never). Only drug injecting experience
was included in the analysis. Major drug type and detoxifi-
cation experience were not included because more than
90% of individuals were heroin addicts and almost all of
them had detoxification experience. Drug use during the
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since they were highly correlated with injecting drug
experience. All clinic level variables mentioned above were
included. Clinic healthcare personnel (physicians and
nurses) and total number of individuals at each clinic were
fitted as continuous variables. The form of the binomial
logit 2-level model and interpretation are described else-
where [18]. Stepwise selection was used to choose the vari-
ables for the final model, first using individual level
variables and then using clinic level variables. The final
model was designed by first including all variables in the
model that were significant and then examining the best fit
based on –2log-likelihood values [19]. Models were created
using discrete variables as dummy or grouped continuous
variables and -2log-likelihood values were compared.
Analysis used SAS 9.1 (SAS Institute Inc, Cary, NC,
USA) except for the multilevel analysis which used MLwiN
2.02 (http://www.cmm.bristol.ac.uk/MLwiN/). Reported
p-values were two-sided and a p-value below 0.05 was
judged significant.Table 1 Individual-level characteristics associated with HIV an
Variables No. of patients (%)
N
Overall 13270(100) 100
Sex
Male 12463(93.9) 940
Female 807(6.1) 64
Age
<20 years old 36(0.3) 25
20-29 years old 3242(24.4) 234
30-39 years old 7725(58.2) 590
40-49 years old 2080(15.7) 162
50-59 years old 177(1.3) 14
>59 years old 10(0.1) 7
Marital status
Married 6446(48.6) 491
Unmarried 6824(51.4) 513
Education
None/primary school 2760(20.8) 169
Middle school 8325(62.7) 629
High school and above 2185(16.5) 205
Employment status
Employed 4926(37.1) 375
Unemployed 8344(62.9) 629
Ever injected drugs
Yes 11011(83.0) 834
No 2259(17.0) 169
Note: uptake is defined as completion of HIV or HCV test at an associated laboratorEthics statement
This study was approved by the Guangdong Provincial
Health Bureau and the Ethics Review Committee at Sun
Yat-sen University. Written informed consent was pro-
vided by clinic directors and all patients. The patient
consent included permission to upload information into
the national web-based administrative database.
Results
Socio-demographic characteristics of participants
and characteristics of clinics
A total of 13,270 individuals were included in this ana-
lysis. Most individuals were male (93.9%) and heroin
users (99.6%). 82.6% were between 20 years old and
40 years old. Most individuals had completed nine years
or less of school and were unemployed at the time of
the survey (Table 1).Twenty-five out of the 45 clinics
were located in the prosperous Pearl River Delta region
of the province. 82.2% of clinics were at the city level.
The median total number of methadone clients seen ind HCV test uptake at methadone clinics (N=13270)
HIV uptake HCV uptake
o. (%) p No. (%) p
46(75.7) 10404(78.4)
0(75.4) 0.003 9753(78.3) 0.106
6(80.1) 651(80.7)
(69.4) <0.001 25(69.4) <0.001
6(72.4) 2411(74.4)
7(76.5) 6148(79.6)
1(77.9) 1664(80.0)
0(79.1) 149(84.2)
(70.0) 7(70.0)
1(76.2) 0.208 5079(78.8) 0.288
5(75.3) 5325(78.0)
5(77.6) 0.049 2158(78.2) 0.661
2(75.6) 6517(78.3)
9(74.6) 1729(79.1)
2(76.2) 0.340 3650(74.1) <0.001
4(75.4) 6754(80.9)
8(75.8) 0.512 8663(78.7) 0.091
8(75.2) 1741(77.1)
y.
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ber of healthcare personnel at each clinic was 5 (range
2–10) (Table 2).
Individual-level characteristics associated with HIV
and HCV test uptake
Among all 13,270 individuals, 10,046 (75.7%) had HIV
test uptake and 10,404 (78.4%) had HCV uptake. Among
IDUs and non-IDUs, the HIV prevalence was 7.0% and
0.8%, respectively. Among IDUs and non-IDUs, the
HCV prevalence was 75.5% and 32.6%, respectively. Sev-
eral individual factors were significantly associated with
HIV test uptake and HCV test uptake using univariate
analysis (Table 1). Women had a HIV uptake rate of
80.1% compared to men who had an HIV uptake rate ofTable 2 Clinic-level characteristics associated with HIV and HC
Variables No. of clinics (%)
Overall 45(100)
Economic region
Pearl River Delta* 25(55.6)
Non-Pearl River Delta 20(44.4)
Administrative clinic level
Town/village level 8(17.8)
City level 37(82.2)
Affiliated institution**
Center of Disease Control (CDC) 13(28.9)
Non-CDC 32(71.1)
Clinic healthcare personnel
2-4 staff 13(28.9)
5-7 staff 27(60.0)
8-10 staff 5(11.1)
Total number of patients
<200 patients 17(37.8)
200-399 patients 17(37.8)
>=400 patients 11(24.4)
Provided voluntary HIV counseling or not
Yes 29(64.4)
No 16(35.6)
Average distance from clients’ residence to clinic
≤5 km 20(44.4)
>5 km 25(55.6)
Clinic made profit or not
Yes 19(42.2)
No 26(57.8)
*Pearl River Delta: A dense network of economically developed cities in South Chin
**Affiliated institution: A methadone clinic is not an independently operated institu
Control, public comprehensive hospital or specialist hospital. The affiliated institutio
provides human resources and equipment to the clinic.75.4% (P=0.003). HIV uptake and HCV uptake were in-
creased among older individuals (P<0.001). Individuals
younger than twenty years old had the lowest HIV and
HCV uptake (both were 69.4%) and individuals between
50 to 59 years old had the highest HIV and HCV uptake
(79.1% and 84.2%, respectively). Individuals who were
unemployed had higher HCV uptake (80.9%) than indi-
viduals who were employed (74.1%) (P<0.001).Clinic level characteristics associated with HIV and HCV
test uptake
At the clinic level, the median HIV test uptake among
45 clinics was 86.4% (P25-P75: 71.8%-98.6%) and the me-
dian HCV test uptake was 94.9% (83.1%-97.8%). NoV test uptake at methadone clinics (N=45)
HIV test uptake (%) HCV test uptake (%)
Median P25-P75 P Median P25-P75 P
86.4 71.8-98.6 94.9 83.1-97.8
87.1 79.5-98.7 0.209 94.9 85.0-97.9 0.385
84.8 57.9-97.0 90.4 71.0-97.5
83.1 79.2-97.1 96.8 57.3-97.8
86.8 63.9-98.7 0.894 92.4 83.1-97.8 0.859
86.8 72.9-97.7 0.679 96.1 84.5-96.9 0.940
85.2 63.3-98.7 93.6 82.4-97.9
63.9 54.1-89.7 0.079 83.1 71.0-95.0 0.154
86.2 72.9-98.6 96.4 84.7-98.3
97.7 89.8-98.9 96.6 90.9-99.6
89.7 72.9-97.7 0.462 96.6 86.7-97.9 0.345
86.4 63.9-98.8 92.4 84.5-97.5
82.8 35.0-98.0 84.7 31.8-98.3
86.8 78.9-98.7 0.484 95.0 84.5-97.9 0.652
84.0 57.9-96.8 92.9 81.1-97.4
86.8 62.7-99.0 0.991 88.4 75.0-97.7 0.615
86.2 72.9-97.7 96.1 83.3-97.8
86.2 63.4-98.8 0.973 96.4 85.2-97.8 0.491
86.6 72.1-97.7 88.8 81.8-97.9
a.
tion. Clinics are affiliated to institutions such as a local Center of Disease
n manages the clinic, becomes responsible for administrative issues, and
Table 4 Factors associated with HCV test uptake using
multilevel model
Parameters Estimate(s.e.) Odds ratio
(95% confidence
interval)
P
Null model
Random
Level 2
σ2μO 4.427(0.991) <0.001
Model with explanatory
variables
Random
Level 2
σ2μO 4.103(0.942) <0.001
Fixed
Age
<30 years old - 1
30-39 years old 0.258(0.071) 1.29(1.13,1.49) <0.001
40-49 years old 0.433(0.100) 1.54(1.27,1.88) <0.001
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take based on the univariate analysis (Table 2).
HIV test uptake – individual and clinic level associations
The final two-level logit model showed age, sex, drug
injecting experience and clinic healthcare personnel
were associated with HIV test uptake. Younger individ-
uals were less likely to have HIV test uptake than older
individuals. Non-injecting drug users were more likely
to have HIV test uptake than IDUs (OR=1.16, 95%
CI=1.01-1.33). Women had higher HIV uptake than
men (OR=1.36, 95%=1.08-1.70). Clinics with greater
healthcare personnel had higher HIV uptake (OR=1.55,
95% CI=1.09-2.20) (Table 3).
HCV test uptake – individual and clinic level associations
As shown in Table 4, the final model identifying corre-
lates of HCV test uptake included age, employment sta-
tus and clinic healthcare personnel. Similar to HIV test
uptake data, older individuals were more likely to have
HCV test uptake than younger individuals (the ORTable 3 Factors associated with HIV test uptake using
multilevel model
Parameters Estimate(s.e.) Odds ratio
(95% confidence
interval)
P
Null model
Random
Level 2
σ2μO 4.227(0.947) <0.001
Model with explanatory
variables
Random
Level 2
σ2μO 3.720(0.854) <0.001
Fixed
Age
<30 years old - 1
30-39 years old 0.229(0.062) 1.26(1.11,1.42) <0.001
40-49 years old 0.490(0.087) 1.63(1.38,1.94) <0.001
>50 years old 0.401(0.231) 1.49(0.95,2.35) 0.082
Sex
Male - 1 0.007
Female 0.305(0.114) 1.36(1.08, 1.70)
Ever injected drugs
Yes - 1 0.037
No 0.147(0.070) 1.16(1.01, 1.33)
Clinic healthcare personnel* 0.439(0.178) 1.55(1.09, 2.20) 0.013
*: Healthcare personnel are defined as the total number of physicians and
nurses at the clinic.
>50 years old 0.725(0.302) 2.06(1.14,3.73) 0.016
Employment status
Employed - 1 0.014
Unemployed 0.161(0.066) 1.17(1.03, 1.34)
Clinic healthcare personnel* 0.379(0.188) 1.46(1.01, 2.11) 0.044
*: Healthcare personnel are defined as the total number of physicians and
nurses at the clinic.of 30–39 and 40–49 versus under 30 years are 1.29
(95% CI=1.13-1.49) and 1.54 (95% CI=1.27-1.88)). More
healthcare personnel at the methadone clinic were asso-
ciated with higher HCV test uptake (OR=1.46, 95%
CI= 1.01-2.11). Unemployed individuals were more
likely to have HCV test uptake than employed individuals
(OR=1.18, 95% CI=1.03-1.34).
Correlation between HIV and HCV uptake
There was a significant correlation between HIV test up-
take and HCV test uptake. The correlation coefficient
between HIV test uptake and HCV test uptake was 0.64
(P<0.001). Among the 11,254 individuals who received
either test, 1208 (10.7%) received only HIV testing or
HCV testing, but not both. Women (OR 1.57(95%
CI=1.14-2.15)), individuals 40 to 49 years old (OR 1.53
(95% CI=1.20-1.94)), and non-IDUs (OR 1.42 (95%
CI=1.16- 1.74)) were more likely to have received both
HIV and HCV testing (Table 5).
Discussion
This study reveals an opportunity to expand detection of
bloodborne infections at methadone clinics in China. To
our knowledge, this study is the first to examine inte-
grated HIV and HCV test uptake in Chinese methadone
Table 5 Factors associated with testing for only HIV or
HCV using multilevel model (N=11254)
Parameters Rate of
testing
(%)
Estimate
(s.e.)
Odds ratio (95%
confidence
interval)
P
Null model
Random
Level 2
σ2μO 2.913
(0.629)
<0.001
Model with
explanatory
variables
Random
Level 2
σ2μO 2.866
(0.619)
<0.001
Fixed
Age
<30 years old 10.7 - 1
30-39 years old 10.9 0.166
(0.089)
1.18(0.99, 1.41) 0.0617
40-49 years old 10.0 0.424
(0.122)
1.53(1.20, 1.94) <0.001
>50 years old 12.0 0.027
(0.283)
1.03(0.59, 1.79) 0.924
Sex
Male 10.9 - 1
Female 8.2 0.448
(0.161)
1.57(1.14, 2.15) 0.005
Ever injected
drugs
Yes 11.0 - 1 <0.001
No 9.5 0.349
(0.104)
1.42(1.16, 1.74)
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clinics expanded access to HIV and HCV test among
drug users, but our study found more than 20% of indi-
viduals seen at methadone clinics were still not screened
for HIV or HCV. Older clients and more healthcare
personnel at clinics were both associated with a higher
test uptake. Our large sample size and incorporation of
clinic level factors expands on previous research in this
field [8,20,21].
We found a high rate of HIV and HCV test uptake at
methadone clinics. HIV test uptake rates in our study were
similar to HIV test uptake rates reported in VCT clinics
(72.7%) and STI clinics (81.2%) [18,22]. In China, metha-
done clinics are well positioned to scale up testing because
many new HIV and HCV infections are acquired through
drug use [7]. We found an HCV prevalence (75.5%) higher
than reported in a national systemic review (66.97%) [9].Free HCV testing at methadone clinics eliminates a poten-
tial barrier to screening associated with clinic-based testing.
One study showed IDUs preferred methadone clinics more
than general medicine clinics or specialized clinics as loca-
tions for HIV and HCV testing [23]. Our research suggests
that routine HIV/HCV screening at methadone clinics can
provide a successful model for scaling up HIV/HCV pre-
vention and control programs.
We found younger individuals at methadone clinics
had poor HIV and HCV test uptake. While other Chinese
studies have not observed the same trend [18,24], our find-
ings are consistent with the literature outside of China.
Suboptimal HIV test uptake among youth has also been
noted in the United States, Thailand, and Canada [25-27].
Poor awareness of infection, fear of knowing the results,
and fear of stigma may be exacerbated among drug using
youth [28-30] and were correlated with not receiving HIV
testing among young people [31-33]. Since youth drug
abuse is becoming more common in China [12] and HIV
and HCV infection among young drug users are increasing
[10,34], developing tailored counseling for young individ-
uals at methadone clinics may improve HIV and HCV test
uptake.
Our findings suggest that lack of healthcare personnel
may constrain HIV and HCV testing at methadone
clinics. After adjusting for individual and clinic level
factors, clinics with a higher number of healthcare
personnel (physicians and nurses) were more likely to have
HIV and HCV test uptake. Fewer healthcare personnel
contribute to relatively heavier workloads and may lead to
inadequate counseling during routine testing [35]. National
methadone clinic guidelines require each clinic have two
attending physicians and two nurses with training in men-
tal health, HIV counseling, and methadone maintenance
[13]. Our research found only 23.3% and 34.9% of metha-
done clinics in Guangdong province met these physician
and nurse staffing requirements, respectively [36]. Other
research suggests limited staffing is a problem throughout
China [35] and to a lesser extent, the U.S [37]. Often two
or three part-time clinicians are managing care for more
than 100 patients, including writing prescriptions, provid-
ing counseling and health education, tracking patients lost
to follow-up, and preparing reports [38]. Limited staffing
may contribute to low quality counseling service, a known
barrier to HIV testing [15,24]. Increasing the number of
methadone clinic nurses may help expand routine HIV and
HCV testing.
This study has several limitations. First, our use of
routine monitoring data did not identify reasons for
non-uptake. Although several correlates were associated
with non-uptake, the broader social context of this missed
public health opportunity can only be inferred. Second, our
data were obtained from a single province in South China.
However, Guangdong Province is diverse and draws
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throughout China. Third, some individuals have HIV/HCV
testing in other rehabilitation settings before methadone
treatment, leading to individuals declining repeat testing.
Research examining methadone clients perspectives is ne-
cessary to comprehensively interpret our results. Fourth,
the data was collected at the end of 2008, but national pol-
icies have not changed since then. Finally, we have no data
on the extent of test counseling at each clinic. Measuring
this process outcome is important for ensuring that testing
can be expanded.
Conclusion
Our findings emphasize the need for future research on
test uptake and delivery of services in China’s methadone
clinics. Greater attention to young individuals and metha-
done clinic personnel are warranted. Increasing healthcare
personnel at methadone clinics may increase test uptake.
The use of multilevel modeling allowed examination of
clinic level attributes of test uptake.
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